Accesswire
06 Nov 2025, 21:05 UTC · 49w ago
Verdict
Headline takes no side. We score AMPH +0.60 — strongly bullish.
+0.60strongly bullish
More positive than 78% of ticker scores this week
Which stocks this story touches
More positive than 78% of ticker scores this week
Reported strong quarterly growth driven by BAQSIMI sales, new FDA approval for iron sucrose, and strategic pipeline expansion.
Near neutral — 91% of ticker scores this week are stronger
Mentioned only in the context of historical revenue accounting for BAQSIMI sales.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 32% of relationship scores this week
[mutual] Amphastar assumed global distribution responsibilities for BAQSIMI from Eli Lilly.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
1h ago
+8.1%
Price agrees with the score
$26.20 vs $24.23 close before publication (Nov 6) · not market-adjusted
AMPH chart →
